Bio Techne | TECH - Current Liabilities


Bio Techne reported $163.7M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Bio Techne USD 163.7M 10.42M Jun/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Charles River Laboratories USD 1.13B 41.04M Jun/2026
Danaher USD 9.05B 945M Sep/2026
Illumina USD 1.58B 12M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Merck EUR 8.12B 1.22B Jun/2026
Mettler Toledo International USD 1.2B 92.14M Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Pacific Biosciences Of California USD 68.81M 3.45M Jun/2026
Repligen USD 132.66M 6.45M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Standard Biotools USD 42.2M 66.1M Mar/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Waters USD 2.27B 1.03B Mar/2026